Definium Therapeutics, Inc. (DFTX) Net income 2020–2025
Definium Therapeutics, Inc. (DFTX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$183.8MFY2025 · since FY2020: -$33.9M → -$183.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$183.8M | -69.1% |
| FY2024 | -$108.7M | -13.5% |
| FY2023 | -$95.7M | -68.6% |
| FY2022 | -$56.8M | +39.0% |
| FY2021 | -$93.0M | -174.1% |
| FY2020 | -$33.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice